4//SEC Filing
Guindo Chirfi 4
Accession 0001127602-25-013018
CIK 0000310158other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 5:45 PM ET
Size
9.5 KB
Accession
0001127602-25-013018
Insider Transaction Report
Form 4
Guindo Chirfi
Chief Marketing Officer
Transactions
- Award
Restricted Stock Unit
2025-04-29+5,902→ 5,902 totalFrom: 2026-04-29Exp: 2028-04-29→ Common Stock (5,902 underlying) - Award
Stock Option (Right to Buy)
2025-04-29+26,867→ 26,867 totalExercise: $84.71From: 2026-04-29Exp: 2035-04-28→ Common Stock (26,867 underlying)
Holdings
- 69,826.125
Common Stock
- 55.416(indirect: By 401(k))
Common Stock-401(k) Plan
Footnotes (5)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Includes shares acquired and dividends earned through April 7, 2025 in the Merck U.S. Savings Plan, a 401(k) plan.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
- [F5]The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001722753
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 5:45 PM ET
- Size
- 9.5 KB